Skip to Content

MainStay WMC Intl Research Eq C MYICX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 7.23  /  +1.12 %
  • Total Assets 172.5 Mil
  • Adj. Expense Ratio
    2.270%
  • Expense Ratio 2.270%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.24%
  • Turnover 65%

USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:06 PM GMT+0

Morningstar’s Analysis MYICX

Will MYICX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay WMC Intl Research Eq C's Average People Pillar and Process Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MYICX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Taiwan Semiconductor Manufacturing Co Ltd ADR

3.20 5.7 Mil
Technology

ASML Holding NV

2.29 4.1 Mil
Technology

Shell PLC

1.95 3.5 Mil
Energy

Novo Nordisk A/S Class B

1.90 3.4 Mil
Healthcare

TotalEnergies SE

1.88 3.3 Mil
Energy

Unilever PLC

1.88 3.3 Mil
Consumer Defensive

Tencent Holdings Ltd

1.71 3.0 Mil
Communication Services

HSBC Holdings PLC

1.44 2.6 Mil
Financial Services

Alimentation Couche-Tard Inc

1.42 2.5 Mil
Consumer Cyclical

Haleon PLC

1.39 2.5 Mil
Healthcare